Lidocaine nonclinical toxicology: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Nonclinical Toxicology== | ==Nonclinical Toxicology== | ||
'''Carcinogenesis, Mutagenesis, Impairment of Fertility''' | |||
Long term studies in animals to evaluate the carcinogenic and mutagenic potential or the effect on fertility of Xylocaine have not been conducted.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION [ASTRAZENECA LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=723c8e7e-75eb-4119-4ab0-ab52955869f7#nlm34067-9 | publisher = | date = | accessdate = }}</ref> | Long term studies in animals to evaluate the carcinogenic and mutagenic potential or the effect on fertility of Xylocaine have not been conducted.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION [ASTRAZENECA LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=723c8e7e-75eb-4119-4ab0-ab52955869f7#nlm34067-9 | publisher = | date = | accessdate = }}</ref> | ||
Revision as of 15:58, 11 March 2014
| Lidocaine |
|---|
| XYLOCAINE® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Lidocaine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Nonclinical Toxicology
Carcinogenesis, Mutagenesis, Impairment of Fertility Long term studies in animals to evaluate the carcinogenic and mutagenic potential or the effect on fertility of Xylocaine have not been conducted.[1]
References
Adapted from the FDA Package Insert.